Correlation Between Oncolytics Biotech and Surrozen

Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and Surrozen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and Surrozen into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Oncolytics Biotech and Surrozen, you can compare the effects of market volatilities on Oncolytics Biotech and Surrozen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of Surrozen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and Surrozen.

Diversification Opportunities for Oncolytics Biotech and Surrozen

0.27

Correlation Coefficient

Oncolytics Biotech  Surrozen

Modest diversification

The 3 months correlation between Oncolytics and Surrozen is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and Surrozen in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surrozen and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with Surrozen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surrozen has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and Surrozen go up and down completely randomly.

Pair Corralation between Oncolytics Biotech and Surrozen

Given the investment horizon of 90 days Oncolytics Biotech is expected to under-perform the Surrozen. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.3 times less risky than Surrozen. The stock trades about -0.02 of its potential returns per unit of risk. The Surrozen is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  821.00  in Surrozen on September 17, 2024 and sell it today you would earn a total of  164.00  from holding Surrozen or generate 19.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Oncolytics Biotech  vs.  Surrozen

Oncolytics Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Oncolytics Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest inconsistent performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Surrozen

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Surrozen are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Surrozen displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Oncolytics Biotech and Surrozen

The main advantage of trading using opposite Oncolytics Biotech and Surrozen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, Surrozen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will offset losses from the drop in Surrozen's long position.

The idea behind Oncolytics Biotech and Surrozen pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.